The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2026. Part VIIIA – Basic prices of drugs Contractors should note changes made to the notes to Part VIIIA regarding Categories A, C, H and M.
Read moreA falsified version of Mounjaro (tirzepatide) KwikPen 15mg solution for injection has been found supplied through one online pharmacy in the UK. The falsified product is labelled with batch D873576 and applies to Mounjaro KwikPen 15mg solution for injection in pre-filled pen only. The issue was identified due to faults with the pens, where in
Read moreMHRA Class 4 Medicines Defect Notification: Dropodex 0.1% w/v Eye Drops, solution (Rayner Pharmaceuticals Limited) Drug alert number: EL(26)A/10 Date issued: 24 February 2026 Rayner Pharmaceuticals limited have informed the MHRA that the batches listed in this notification do not include the concentration of phosphates in the product information. DMRC reference number: DMRC-38371734 Marketing Authorisation Holder: Rayner
Read moreMHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) Drug alert number: EL(26)A/09 Date issued: 23 February 2026 Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results. DMRC reference number: DMRC-38487919 Company name: Sterling
Read moreCommunity Pharmacy England met in London for a full Committee meeting on 4th and 5th February. Committee Members examined economic and other analysis to confirm key negotiating positions for the imminent 2026/27 contractual negotiations, looking at a wide range of topics including funding needs, services, infrastructure investment, and regulatory reform. The Department of Health and Social Care and
Read moreThe Department of Health and Social Care launched a public consultation on proposed amendments to the Health Service Products (Provision and Disclosure of Information) Regulations. The Regulations, introduced in 2018, enable the Department to collect information on the costs of medicines, appliances, and borderline substances to be dispensed for the NHS. The key impact on
Read moreThe Department of Health and Social Care (DHSC) has today (19/02/2026) confirmed the following list of price concessions for February 2026: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.71 Aspirin 75mg tablets 28 £2.17 Benzydamine 0.15% mouthwash sugar free 300 £3.31 Carbocisteine 375mg capsules 120 £3.75 Cefalexin 125mg/5ml oral suspension sugar free 100
Read moreCommunity Pharmacy England held a webinar on the new Part VIIIA Drug Tariff category, Category H, on Monday 16 February. A subset of Category C drugs with multiple suppliers will be listed in Category H in Part VIIIA of the Drug Tariff. The Department of Health and Social Care is starting by moving 11 products
Read moreAs part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff funding and regulatory experts have created a new video on out-of-pocket (OOP) expenses. In this video, we explain how pharmacy teams can claim out-of-pocket expenses incurred when obtaining eligible drugs or appliances for dispensing against NHS prescriptions. We also cover
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Sodium valproate (Epilim Chronosphere®) 100mg modified-release granules sachets sugar free. MSN/2026/012 Tier 2 – Medium impact Date of issue: 17 February 2026 Sodium valproate (Epilim Chronosphere®) 100mg modified release granules sachets sugar free will be out of stock from late February
Read more
